Walgreens will sell its six-building office campus, where it will remain a tenant, for $85 million, according to a report published Tuesday by Chicago Real Estate Daily.
Weis Markets on Thursday announced it would invest $135 million in its 2013 capital expenditure program, an 8% increase compared to the year prior.
Avella Specialty Pharmacy provided more than $7.2 million in financial assistance to patients last year, the company said Thursday.
Actavis can launch a generic version of an attention deficit hyperactivity disorder drug made by Shire next year under an agreement between the two companies announced Thursday.
Cardinal Health and McKesson separately announced the renewal of their pharmaceutical distribution agreements with CVS Caremark.
Greenstone has launched an authorized generic painkiller, the company said.
Safeway shares dropped dramatically Thursday morning as the company reported $10 billion in sales for its first quarter 2013 ended March 23, which is essentially flat as compared with the first quarter of 2012.
Galderma, whose brands include Cetaphil, and The American Academy of Dermatology have announced the creation of the American Academy of Dermatology Translational Biotechnology Fellowship.
Beauty brand Revlon posted a net loss during the first quarter, including charges, as net sales rose 2.1%, excluding the unfavorable impact of foreign currency fluctuations.